CLDN3 and cancer: In total, 13 ofthe 27 genes identified in three or more array datasets, have previously beendescribed by independent studies to be differentially expressed in ovarian cancerspecimens, including EPCAM, CLDN3,PTK2 and TPD52 while a further 11 genes havebeen investigated in the context of other cancers.